UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IPD1.07 Environmental sampling for fungal species in a UK cystic fibrosis centre

Journal of cystic fibrosis, 2017-06, Vol.16, p.S57-S57

2017

Volltextzugriff (PDF)

Association of airway cathepsin B and S with inflammation in cystic fibrosis

Pediatric pulmonology, 2010-09, Vol.45 (9), p.860-868

2010

Volltextzugriff (PDF)

WS14.5 Clinical outcomes of adult cystic fibrosis patients with aspergillus disease in a 5 year period

Journal of cystic fibrosis, 2017-06, Vol.16, p.S26-S26

2017

Volltextzugriff (PDF)

118 Comparison of alternate month versus continuous Cayston™ in adults with cystic fibrosis

Journal of cystic fibrosis, 2016-06, Vol.15, p.S81-S81

2016

Volltextzugriff (PDF)

ePS06.10 Antibiotic desensitisation: a single centre review of 2015

Journal of cystic fibrosis, 2016-06, Vol.15, p.S50-S50

2016

Volltextzugriff (PDF)

119 The impact of the initiation of aztreonam solution for inhalation (Cayston™) on symptoms, treatment burden and lung function in adults with cystic fibrosis

Journal of cystic fibrosis, 2016-06, Vol.15, p.S81-S81

2016

Volltextzugriff (PDF)

43 Gram-negative emerging pathogens: Prevalence and strain typing results from a large UK adult CF centre

Journal of cystic fibrosis, 2015-06, Vol.14, p.S68-S68

2015

Volltextzugriff (PDF)

165 “Real world” introduction of tobramycin inhalation powder TIP™ in adults with cystic fibrosis

Journal of cystic fibrosis, 2015-06, Vol.14, p.S100-S100

2015

Volltextzugriff (PDF)

WS08.3 “Real world” experience of introduction of Colobreathe™ (Colo) in adults with cystic fibrosis

Journal of cystic fibrosis, 2015-06, Vol.14, p.S15-S15

2015

Volltextzugriff (PDF)

WS19.6 Changes in the weather and the respiratory health of adults with cystic fibrosis

Journal of cystic fibrosis, 2013-06, Vol.12, p.S39-S39

2013

Volltextzugriff (PDF)

137 Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection

Journal of cystic fibrosis, 2013-06, Vol.12, p.S83-S83

2013

Volltextzugriff (PDF)

122 The impact of human rhinovirus infection on the cystic fibrosis lung microbiome

Journal of cystic fibrosis, 2013-06, Vol.12, p.S79-S79

2013

Volltextzugriff (PDF)

241 Iatrogenic suppression of the hypothalamic-pituitary-adrenal axis in cystic fibrosis; a cause for concern

Journal of cystic fibrosis, 2012-06, Vol.11, p.S118-S118

2012

Volltextzugriff (PDF)

71 Is a once daily dose of 5mg/kg a sensible compromise between the risks and benefits of intravenous tobramycin?

Journal of cystic fibrosis, 2012-06, Vol.11, p.S74-S74

2012

Volltextzugriff (PDF)

124 Ribosomal RNA intergenic spacer analysis (RISA) as a rapid and diagnostic means to profile microbial diversity in cystic fibrosis sputum

Journal of cystic fibrosis, 2013-06, Vol.12, p.S80-S80

2013

Volltextzugriff (PDF)

134 Validity of a symptom questionnaire for the diagnosis of viral respiratory infection in adults with CF

Journal of cystic fibrosis, 2012-06, Vol.11, p.S90-S90

2012

Volltextzugriff (PDF)

Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa

The European respiratory journal, 2003-09, Vol.22 (3), p.503-506

2003

Volltextzugriff (PDF)

P189 Impact of triple CFTR modulation therapy on non-invasive ventilation use in adults with cystic fibrosis

Journal of cystic fibrosis, 2021, Vol.20, p.S96-S97

2021

Volltextzugriff (PDF)

P188 Non-invasive ventilation use and management of adult cystic fibrosis patients at end of life

Journal of cystic fibrosis, 2021, Vol.20, p.S96

2021

Volltextzugriff (PDF)

Subsidising exercise in the community: the benefits for adults with cystic fibrosis

Journal of cystic fibrosis, 2009, Vol.8, p.S76-S76

2009

Volltextzugriff (PDF)

Ototoxicity in Adults with Cystic Fibrosis

Journal of cystic fibrosis, 2009, Vol.8, p.S48-S48

2009

Volltextzugriff (PDF)

ePS1.01 Long-term outcomes of adult patients with cystic fibrosis requiring non-invasive ventilation

Journal of cystic fibrosis, 2020-06, Vol.19, p.S37-S37

2020

Volltextzugriff (PDF)

Use and perceived benefits of nebulised hypertonic saline (HS) treatment in adult patients with cystic fibrosis

Journal of cystic fibrosis, 2008-06, Vol.7, p.S71-S71

2008

Volltextzugriff (PDF)

P036 Relationship between phenotype and genotype in an older cystic fibrosis cohort

Journal of cystic fibrosis, 2020-06, Vol.19, p.S65-S65

2020

Volltextzugriff (PDF)

ePS2.02 Assessing cardiovascular risk in an older cystic fibrosis patient cohort: implications of Cystic Fibrosis-Related Diabetes classification

Journal of cystic fibrosis, 2020-06, Vol.19, p.S40-S40

2020

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(88)

Sprache

Englisch
(88)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IPD1.07 Environmental sampling for fungal species in a UK cystic fibrosis centre

Association of airway cathepsin B and S with inflammation in cystic fibrosis

WS14.5 Clinical outcomes of adult cystic fibrosis patients with aspergillus disease in a 5 year period

118 Comparison of alternate month versus continuous Cayston™ in adults with cystic fibrosis

ePS06.10 Antibiotic desensitisation: a single centre review of 2015

119 The impact of the initiation of aztreonam solution for inhalation (Cayston™) on symptoms, treatment burden and lung function in adults with cystic fibrosis

43 Gram-negative emerging pathogens: Prevalence and strain typing results from a large UK adult CF centre

165 “Real world” introduction of tobramycin inhalation powder TIP™ in adults with cystic fibrosis

WS08.3 “Real world” experience of introduction of Colobreathe™ (Colo) in adults with cystic fibrosis

WS19.6 Changes in the weather and the respiratory health of adults with cystic fibrosis

137 Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection

122 The impact of human rhinovirus infection on the cystic fibrosis lung microbiome

241 Iatrogenic suppression of the hypothalamic-pituitary-adrenal axis in cystic fibrosis; a cause for concern

71 Is a once daily dose of 5mg/kg a sensible compromise between the risks and benefits of intravenous tobramycin?

124 Ribosomal RNA intergenic spacer analysis (RISA) as a rapid and diagnostic means to profile microbial diversity in cystic fibrosis sputum

134 Validity of a symptom questionnaire for the diagnosis of viral respiratory infection in adults with CF

Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa

P189 Impact of triple CFTR modulation therapy on non-invasive ventilation use in adults with cystic fibrosis

P188 Non-invasive ventilation use and management of adult cystic fibrosis patients at end of life

Subsidising exercise in the community: the benefits for adults with cystic fibrosis

Ototoxicity in Adults with Cystic Fibrosis

ePS1.01 Long-term outcomes of adult patients with cystic fibrosis requiring non-invasive ventilation

Use and perceived benefits of nebulised hypertonic saline (HS) treatment in adult patients with cystic fibrosis

P036 Relationship between phenotype and genotype in an older cystic fibrosis cohort

ePS2.02 Assessing cardiovascular risk in an older cystic fibrosis patient cohort: implications of Cystic Fibrosis-Related Diabetes classification

Suchergebnisse filtern